An Overview of SARS-CoV-2 Molecular Diagnostics in Europe
- PMID: 35636820
- PMCID: PMC8901364
- DOI: 10.1016/j.cll.2022.02.005
An Overview of SARS-CoV-2 Molecular Diagnostics in Europe
Abstract
The COVID-19 pandemic has led to the rapid development of a plethora of molecular diagnostic assays with real-time polymerase chain reaction (RT-PCR) at the forefront. In this review, we will discuss the history and utility of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) molecular diagnostics and the associated current and future regulatory process in Europe. We will assess the performance characteristics of a range of the most common SARS-CoV-2 molecular tests currently used in Europe with a focus on as rapid molecular platforms, stand-alone RT-PCR kits, the role of low-throughput and high-throughput end-to-end testing platforms, and the rapidly evolving field of SARS-CoV-2 variant of concern identification.
Keywords: CE Marking; COVID-19; Molecular diagnostics; RT-PCR; SARS-CoV-2.
Crown Copyright © 2022. Published by Elsevier Inc. All rights reserved.
References
-
- ProMED-mail. Published Date : 2020-01-05 18 : 15 : 37 Subject : PRO/AH/EDR > Undiagnosed Pneumonia - China ( HU ) ( 03 ): Updates , SARS , MERS Ruled out , WHO , RFI Archive Number : 20200105 . 6872267.; 2020.
-
- Zhang Y-Z. Initial genome release of novel coronavirus. Virological. Available at: https://virological.org/t/novel-2019-coronavirus-genome/319. 2020. Accessed June 23, 2021.
-
- World Health Organization. Novel coronavirus (2019-NCoV) situation reports. Available at: https://www.who.int/docs/default-source/coronaviruse/situation-reports/2.... 2020. Accessed June 23, 2021.
-
- World Health Organization. Naming the coronavirus disease (COVID-19) and the virus that causes it. Available at: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/technica.... 2020. Accessed June 23, 2021.
Publication types
MeSH terms
Supplementary concepts
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous